Nanosilver induces minimal lung toxicity or inflammation in a subacute murine inhalation model
© Stebounova et al; licensee BioMed Central Ltd. 2011
Received: 29 September 2010
Accepted: 25 January 2011
Published: 25 January 2011
There is increasing interest in the environmental and health consequences of silver nanoparticles as the use of this material becomes widespread. Although human exposure to nanosilver is increasing, only a few studies address possible toxic effect of inhaled nanosilver. The objective of this study was to determine whether very small commercially available nanosilver induces pulmonary toxicity in mice following inhalation exposure.
In this study, mice were exposed sub-acutely by inhalation to well-characterized nanosilver (3.3 mg/m3, 4 hours/day, 10 days, 5 ± 2 nm primary size). Toxicity was assessed by enumeration of total and differential cells, determination of total protein, lactate dehydrogenase activity and inflammatory cytokines in bronchoalveolar lavage fluid. Lungs were evaluated for histopathologic changes and the presence of silver. In contrast to published in vitro studies, minimal inflammatory response or toxicity was found following exposure to nanosilver in our in vivo study. The median retained dose of nanosilver in the lungs measured by inductively coupled plasma - optical emission spectroscopy (ICP-OES) was 31 μg/g lung (dry weight) immediately after the final exposure, 10 μg/g following exposure and a 3-wk rest period and zero in sham-exposed controls. Dissolution studies showed that nanosilver did not dissolve in solutions mimicking the intracellular or extracellular milieu.
Mice exposed to nanosilver showed minimal pulmonary inflammation or cytotoxicity following sub-acute exposures. However, longer term exposures with higher lung burdens of nanosilver are needed to ensure that there are no chronic effects and to evaluate possible translocation to other organs.
With increasing use of manufactured nanoparticles the potential for exposure among manufacturers and consumers is also increasing. Many of these manufactured nanomaterials are composed of metal and metal oxides and there have been reports of metal-containing nanoparticles in workplaces , from industrial sources detected in the atmosphere [2, 3] and in surface waters [4, 5]. Silver nanoparticles, often referred to as nanosilver, may be problematic because of their use in a wide range of applications due to their antimicrobial activity [6–8]. Nanosilver is used for treatments of wounds, burns, water or air disinfection, or as coatings on various textiles . There is concern that little is known about the environmental and health consequences of exposure to nanosilver.
Prior in vitro studies of nanosilver toxicity [10–15] reveal toxic effects of nanosilver through reduced cell viability, damage to the cell membrane and other biological effects on the organism. Nanosilver has been reported to be among the most toxic nanomaterials in some studies [10, 16–18]. The cytotoxicity of nanosilver has been associated with generation of reactive oxygen species [10, 19] and several studies suggest that nanosilver is only toxic when oxidized to silver ions, Ag+ [12, 14].
Most of the in vitro studies show dose dependence, where higher doses of Ag induce higher cellular toxicity. In contrast to in vivo investigations, in vitro concentrations of nanoparticles are often much higher and the particles are delivered to the cells via the culture medium. Such exposures do not replicate the conditions expected for in vivo exposure. Currently, there is no direct correlation of biological markers of toxicity between in vivo and in vitro studies due to the complexity of dose delivery, mono- vs. co-cultures, endpoint evaluations as well as other factors of cellular interaction with different biological media [20, 21]. Even though air-liquid in vitro systems have been recently developed that may have more predictive value [22–25], in vivo studies are still considered to be more relevant for risk assessment.
Although inhalation is considered the most important route of exposure for nanoparticles [26, 27], little is known about the environmental and health risks of aerosolized nanosilver . There are a few reports in the literature on pulmonary studies of nanosilver toxicity in rats [7, 29–32]. In these studies silver was detected in the lungs and, at much lower concentration, in the liver, brain, olfactory bulb and blood indicating organ translocation of nanosilver. No significant health implications were found for short exposure time periods although some pathologic responses were observed for higher Ag doses or longer exposures, such as chronic alveolar inflammation, small granulomatous lesions, and a decrease in the tidal and minute volume of the lungs. However, there are significant gaps in the toxicity studies of nanosilver and more thorough investigations with well characterized materials are warranted .
An integrated approach that includes both inhalation toxicology studies and full characterization of the nanomaterials is necessary for understanding inflammatory responses as they relate to the physicochemical principles of nanoparticle toxicity. In the current study, such an approach is used to assess the potential toxic effects associated with the inhalation of commercial nanosilver using a murine model for lung inflammation, histopathology, and dosimetry.
Materials and methods
Nanosilver with a manufacturer's stated average particle size of 10 nm (minimum 5 nm, maximum 15 nm, BET= (10 + 1) m2/g) were in powder form and used as received from the manufacturer (Stock # 0478 YD, Nanostructured and Amorphous Materials, Inc, Houston, TX).
The nanosilver was characterized using transmission electron microscopy (TEM), X-ray diffraction (XRD), X-ray photoelectron spectroscopy (XPS), and BET techniques . The bulk crystalline phases of Ag nanoparticles were determined using powder XRD measurements (Bruker D-5000 q - q diffractometer with Kevex-sensitive detector, Madison, WI). TEM (JEOL JEM-1230, Japan) was used to measure the primary particle size of 500 random nanoparticles and compare the average to manufacturer's specifications.
Surface properties, surface area, and composition of the Ag nanoparticles were examined. Surface area measurements of the powder sample were made on automated multipoint BET surface area apparatus (Quantachrome Nova 4200e, Boynton Beach, Florida) using nitrogen as the adsorbent. X-ray photoelectron spectroscopy (XPS) was used to probe the surface chemical composition characteristics of the metal nanoparticles (custom-designed Ultra-Axis XPS system from Kratos, Manchester, UK).
Dissolution studies were conducted in two different types of artificial fluids using inductively coupled plasma optical emission spectrometer (ICP-OES) (Varian Inc. 720-ES, Walnut Creek, CA). Ag nanoparticles were incubated in artificial interstitial fluid (Gamble's solution, pH = 7.4) and artificial lysosomal fluid (ALF, pH = 4.5) at a concentration of 2 mg/ml for 24 hours at 38°C. The ALF solution simulates the composition and pH of alveolar and interstitial macrophages and the Gamble's solution simulates interstitial fluid in the lungs . The compositions of the simulated biological fluids can be found in Ref. . The final solutions were filtered by a syringe through 0.2 μm filter and centrifuged for 30 minutes at 14,000 rpm in order to remove nanoparticles and aggregates that were not dissolved. The filtered and centrifuged solutions were analyzed by ICP-OES.
Male (6 weeks old) C57Bl/6 mice (The Jackson Laboratory, Bar Harbor, ME) were quarantined for 12 days after their arrival in our vivarium in polypropylene, fiber-covered cages in HEPA-filtered Thoren caging units (Hazelton, PA) in the Pulmonary Toxicology Facility at the University of Iowa prior to use. Mice were supplied with food (sterile Teklad 5% stock diet, Harlan, Madison, WI) and water ad libitum and maintained on a 12-hr light-dark cycle. The average weight of the animals at the time of necropsy was 22.4 g at 0 wk post exposure and 26.8 g at 3 weeks post exposure. Sham-exposed control mice had a mean weight of 26.9 g at the time of necropsy. Protocols were approved by the Institutional Animal Care and Use Committee at the University of Iowa and complied with the NIH Guide for the Care and Use of Laboratory Animals.
Exposure Generation and Characterization
A dynamic whole-body exposure chamber  was used to expose animals to nanosilver. Sham-exposed mice breathed filtered room air in an identical chamber setup. A suspension of nanosilver in ultra-pure water (Milli-Q® Academic A-10, Millipore Corp., Billerica, MA) was ultra-sonicated (model 550, Fisher Scientific, Pittsburgh, PA) for 20 min. Aerosols of this suspension were generated using a 6-jet Collison nebulizer (BGI Inc., Waltham, MA) supplied with filtered, pressurized air (24 psi) and passed through a 60 cm × 2 cm (I.D.), brass drying column heated to 110°C as well as a 20 mCi 63Ni source to completely evaporate droplets and neutralize charges on the particles prior to introduction into the exposure chamber. Gravimetric concentrations of particles were measured in the chamber using 47-mm glass microfiber filters (Whatman, Middlesex, United Kingdom) in line with the 24 l/min exhaust airflow. With the additional heat and humidity supplied to the chamber, the temperature and relative humidity in the exposure chamber during the experiments was controlled between 20-22°C and 25-35%, respectively. Electron microscopy grids were placed inside the exposure chamber for analysis of deposited nanoparticles. The grids were analyzed using scanning electron microscopy with an energy dispersive spectrometer (SEM-EDS) (Hitachi S-3400N, Japan) capable of providing elemental analysis of the particles. This confirmed the presence of nanosilver on the grid from the whole-body chamber during inhalation exposures. The size distribution of the aerosol in the whole-body exposure chamber was measured using a scanning mobility particle sizer (SMPS, TSI Inc., Shoreview, MN) for diameters in the range of 7.4 to 289 nm. Geometric mean (GM) and geometric standard deviation (GSD) of aerosol sizes in individual exposures were calculated from SMPS measurements.
Mice were euthanized by isoflurane inhalation and exsanguination through the heart. Lungs (from 5 animals per each experimental group) were lavaged 3 times with 1 ml of 0.9% sterile sodium chloride solution (Baxter, Deerfield, IL) and the cell pellet was used for enumeration of total and differential cell counts as previously described . Cells recovered from bronchoalveolar lavage (BAL) fluid were processed for TEM-EDS analyses (n = 1). Macrophages recovered from BAL fluid with and without Ag particles (100 cells per sample) were counted using dark field microscopy to assess the extent of the phagocytosis. The lavage supernatants (n = 5) were analyzed for total protein in 4 dilutions (1:5, 1:10, 1:20, and 1:40) using a Bradford protein assay (Bio-Rad Laboratories, Inc., Hercules, CA), lactate dehydrogenase (LDH) activity was measured in duplicates with a commercial assay (Roche Diagnostics, Penzberg, Germany) and cytokine levels measured by multiplexed fluorescent bead-based immunoassays (Bio-Plex Pro Mouse Cytokine, Chemokine, and Growth Factor Multiplex Assays, Bio-Rad Laboratories, Inc., Hercules, CA). Measured cytokines included: interleukin (IL)-6, IL-12(p40), tumor necrosis factor (TNF)-α, granulocyte macrophage colony stimulating factor (GM-CSF), keratinocyte-derived cytokine (KC), monocyte chemotactic protein (MCP)-1, and macrophage inflammatory protein (MIP)-1α. The BAL fluid (n = 5) was then centrifuged again at 22,000 rpm for 30 min and Ag concentration in BAL supernatants was measured by ICP-MS.
Lungs from non-lavaged mice (n = 3) were fixed in 10% formaldehyde-phosphate-buffered saline solution via the canulated trachea. The tissues were paraffin-embedded, sectioned at 5 μm, and stained with hematoxylin and eosin (H & E) as previously described . Tissue sections were evaluated by light microscopy to elucidate abnormalities of the parenchymal architecture (bronchioles, alveoli, pleura, and vasculature); abnormal inflammatory infiltrates; presence or absence of acute lung injury; and presence or absence of fibrosis.
Lung, brain, heart, and liver tissues from 5 mice in each experimental group were stored at -80°C immediately after resection. Tissues were lyophilized for 16 hours at 1.3 × 10-1 mBar and -50°C in a freeze dryer (Labconco Corp., Kansas City, MO) and then weighted. High purity concentrated nitric acid (Fisher Optima® grade) was used to digest the tissues at 95-98°C. Metal analysis was performed using ICP-OES (Varian 720 ES, Varian Inc., Walnut Creek, CA) with a method detection limit for Ag of 1.8 μg/g lung dry weight (d.w.).
EDS-spectra of Ag nanoparticles in alveolar macrophages
The BAL cells were fixed with 2.5% glutaraldehyde in 0.1M Na cacodylate buffer, post fixed with 1% osmium tetroxide, dehydrated through graded ethanols and embedded in epoxy resin. Thins sections were cut at ~80-90 nm on a Leica EM UC6 ultramicrotome (Leica Microsystems GmbH, Wetzlar, Germany) and placed on 200 mesh formvar/carbon coated nickel grids. Elemental analysis of the cells recovered from BAL was performed with a Thermo Fisher Noran System 7 (Waltham, MA) energy dispersive spectroscopy system (EDS) attached to a JOEL JEM-2100F (Tokyo, Japan) field emission transmission electron microscope. The TEM was operated at an accelerating voltage of 200 kV in scanning mode combined with a high angle annular field detector (HAADF). NSS 2.2 software package was used to acquire and process the data.
Data from nanosilver-exposed and sham-exposed animals were compared using t tests for equal or unequal variances (SAS Ver. 9.2, SAS, Inc., Cary, NC). A p-value less than 0.05 was considered significant. Data are expressed as mean ± standard error (SE) unless otherwise noted.
Summary of physicochemical characterization data of Ag nanoparticles and Ag nanoparticle aerosols
Primary Particle Size*
5 ± 2 nm; 22 ± 4 nm
Crystalline or Amorphous Material, phase
Crystalline, face-centered cubic, metal
CO3 2-, OH-, C=O, C-O-C
BET Surface Area
3 ± 2 m2/g
3.3 ± 0.5 mg/m3
Aerosol Size Distribution**
79 nm (1.5)
A primary particle size distribution was generated from the TEM images (Figure 2C) by measuring the two-dimensional diameter of more than 500 nanoparticles (Figure 2D). The first mode of the bimodal particle size distribution with a peak maximum at 5 nm accounted for 85 to 90% of the total particle count. The second mode, with a peak at 22 nm, was attributed to larger particles that account for less than 15% of the total particle count.
The median amount of silver measured by ICP-OES in the lungs of nanosilver-exposed mice necropsied immediately after the exposure (0 wk group) was 31 μg/g lung (d.w.) (range 4.3 to 37.5 μg/g lung (d.w.)). This represents the loading in the lungs but not the nose, nasopharynx or trachea, which were not measured. The lungs of the 3 wk mice had a median silver content of 10 μg/g lung (d.w.), and two of these five mice had no detectable silver. The mass concentration of silver in all sham-exposed mice was below the detection limit (1.8 μg/g lung (d.w.)). Silver concentrations in the heart, liver, and brain were all below the detection limit. Assuming a minute volume of 25 ml/min, an aerosol concentration of 3.3 mg/m3 and a deposition coefficient of 0.15 in the tracheo-bronchiolar and pulmonary region, we estimate that 803 μg Ag/g lung (d.w.) was delivered to the lungs. Thus, 4% of the nominal Ag dose was found in the pulmonary region.
Bronchoalveolar Lavage Fluid
Cytokine concentrations in BAL fluid from mice exposed to Ag nanoparticles by inhalation. Data from Ref. 34 for Cu nanoparticle exposure using the same protocol are shown for comparison.
29.1 ± 2.9
Ag 0 wk post exposure
64.1 ± 10.6*
4.24 ± 0.88*
Ag 3 wks post exposure
53.6 ± 21.9
2.96 ± 0.54
35.0 ± 6.8
21.4 ± 3.3
0.90 ± 0.12
0.16 ± 0.08
Cu 0 wk post-exposure
82.8 ± 13.8*
1210 ± 10.1*
161 ± 10.4*
215 ± 17.0*
4400 ± 401*
309 ± 37.2*
70.2 ± 10.9*
Cu 3 wk post-exposure
42.7 ± 4.8
17.3 ± 1.6
1.44 ± 0.12
0.27 ± 0.13
The mean concentrations of Ag ion in BAL supernatants were 13.9 ± 0.9 μg/L and 1.7 ± 0.2 μg/L in animals necropsied at 0 wk and 3 wks post exposure, respectively. Silver was not detectable in BAL fluid from control mice.
The purpose of this study was to assess the biological response of mice to inhaled nanosilver and to determine the amount of silver retained in lungs and other organs. We observed nanosilver agglomerates in the inhalation chamber with a GM mobility diameter of 79 nm (Table 1) and SEM-EDS analysis showed the presence of Ag aerosols in the exposure chamber (Figure 4). ICP-OES analysis of nanosilver incubated in the simulated biological fluids revealed negligible formation of Ag ions (Figure 3). Moreover, most of the nanoparticles, even PVP coated particles, aggregated and settled out in these simulated biological fluids at the relatively high concentrations investigated after 24 hours and the XRD analysis of the precipitates revealed the presence of metallic Ag similar to Figure 2A.
Since there are limited data available on the concentrations of nanosilver in consumer products or in the air in occupational settings where materials with nanosilver are being produced, we established exposure concentrations in the whole-body chamber that were similar to our previous studies of toxicity assessment of titanium dioxide, copper, and iron. This facilitated comparison of toxicologic responses with our previous studies with different nanomaterials [34, 41, 42]. The median amount of silver measured in lungs of nanosilver-exposed mice was 31 and 10 μg/g lung (d.w.) for 0 wk and 3 wks animals, respectively, which corresponds to 100 μg/L and 32 μg/L Ag concentrations measured by ICP-OES in the lungs. Moreover, low Ag concentrations in the particle-free supernatants of BAL fluid (13.9 ± 0.9 μg/L and 1.7 ± 0.2 μg/L in animals necropsied at 0 wk and 3 wks post exposure, respectively) were detected by ICP-MS. Higher concentration of Ag measured in BAL fluid from animals necropsied at 0 wk agrees with the higher amount of Ag measured in the 0 wk lungs. Thus, these data suggest that there is some evidence for Ag dissolution in the lungs. It has been shown that Ag nanoparticles might fractionate (or dissolve) in aquatic environments at very low (< 100 μg/L) concentrations since nanoparticles might be less aggregated than in higher concentrated samples [43, 44].
The amount of Ag detected in the 0 wk group corresponds to the lung burden accumulated by a 70 kg person exposed to a very high concentration of 1.0 mg/m3 for 16.6 hours. Hence, this represents a substantial dose. To calculate the exposure time of the human, we assumed exposure concentration of 1.0 mg/m3, frequency of breathing 15 breaths/min, tidal volume of the lungs 600 mL/breath, pulmonary deposition fraction for 80 nm particles of 0.4 (based on human model by Cassee et al. ) and delivered Ag dose to human 3574 μg. The amount of nanosilver measured from the pulmonary region of the exposed mice was below the estimated levels based on the minute ventilation, deposition fraction and gravimetric measurements of chamber outflow. This could be due to lower breathing zone concentrations for the mice than expected from the chamber outflow measurements, an overestimation of the deposition coefficient for the pulmonary region, clearance by mucociliary escalator to the trachea or gastrointestinal tract, translocation of nanosilver to other organs that we did not measure, or poor sensitivity of the ICP-OES assay methods. Work by Asgharian and colleagues has shown that particles below 10 nm are deposited in the nasopharynx and tracheal regions with little penetration into the pulmonary region . Deposition occurs primarily through axial transport by diffusion and convective mixing. Model predictions show that for nanoparticles in the 80 nm range, the deposition fraction for the pulmonary region is about 0.4 in humans (for mouth breathing) and 0.15 in rodents which are obligate nose breathers .
We observed increased total cell numbers in Ag-exposed animals (mainly macrophages) and a slight inflammatory response (increased number of neutrophils in BAL fluid) in 0 wk mice (Figures 5). Recruitment of macrophages is a normal clearance mechanism following particle exposure [45, 46]. Neutrophilia decreased after 3 weeks without exposure, however total number of cells remained elevated. Interestingly, comparison of these results to other metal nanoparticle exposures studied by our group shows that nanosilver is most similar to iron nanoparticles, which are coated with an iron oxide layer. In the previous study, iron nanoparticles were found to be significantly less toxic than copper nanoparticles . Copper nanoparticles induced a 25 times increase in the number of BAL cells after sub-acute exposure as well as an increase in most cytokines.
The levels of total protein and LDH activity in BAL fluid did not change significantly with exposure to nanosilver (Figure 5B). This is another indication of low nanosilver toxicity at the exposure concentration used in this study. Of 7 cytokines tested only two, IL-12(p40) and KC, had slightly elevated concentrations at 0 wk and most were below detection even using a very sensitive assay (Table 2). IL-12(p40), which exhibited the most elevated concentration, functions primarily to induce naïve T-cells to differentiate to Th0 cells and to enhance NK cell activity. It is produced by dendritic cells and macrophages . This is consistent with the observed doubling in BAL macrophages but is very low in comparison to our previous study of Cu nanoparticles when we detected a mean level of IL-12(p40) of 1210 pg/ml (Table 2). Keratinocyte-derived cytokine (KC) that is involved in chemotaxis and cell activiation of neutrophils, was also slightly elevated. However, this increase was 50 times lower than in Cu-exposed mice. Furthermore, other chemokines/cytokines such as MCP-1, MIP-1α, TNF-α, RANTES, GM-CSF were much more elevated in case of Cu nanoparticle exposure .
We observed agglomerated nanosilver in macrophages that were recovered from BAL fluid and also in lung tissue (Figure 6). Dark-field microscopy revealed lower particle load at 3 wks post exposure than immediately post exposure, showing some particle clearance or possible translocation from the airways to the interstitium. Lung tissues were without remarkable pathological changes. In a 90 day rat study, lung inflammation and an increase in granulomatous lesions as well as alterations in lung functions were observed . In another inhalation study in rats, minimal, toxicologically insignificant effects of nanosilver on the nasal respiratory mucosa were indicated .
Here we used the same experimental mouse model and exposure system as in our previous studies on the toxicity of different nanomaterials [34, 41, 42]. Of all nanomaterials studied in the size range from ca. 5 to 20 nm (TiO2, Fe, Cu, Ag), copper nanoparticles, which had a copper oxide coating, induced much higher total cell and neutrophil recruitment in BAL fluid, elevated total protein, activity of LDH and levels of inflammatory cytokines in BAL fluid than nanosilver . This increased inflammatory response in copper-exposed mice was associated with the nanoparticle size and increased ion concentration produced from the dissolving nanoparticles in vivo. Mice exposed sub-acutely to 2-5 nm TiO2 nanoparticles showed a moderate inflammatory response at 0, 1, and 2 weeks post-exposure that resolved after 3 weeks post-exposure. Iron nanoparticles induced a minimal inflammatory response similar to nanosilver. The toxicity of Ag nanoparticles in this murine inhalation model was similar to Fe nanoparticles. Both types do not dissolve in artificial interstitial fluid which could be associated with the negligible toxic response observed for metal and metal oxide nanomaterials. Other studies also support a role for solubility of nanomaterials in their toxicity [51, 52].
The toxicity of nanosilver is a highly debated topic in the literature and in reports of the U.S. Environmental Protection Agency. Our study indicates that 40 hr inhalation of 3.3 mg/m3 nanosilver induced minimal pulmonary toxicity or inflammation. Methods used to evaluate toxic responses in this study indicate much lower inflammatory response of mice to silver nanoparticles than to copper nanoparticles. These observations are in agreement with other studies, which indicate that much higher exposure doses of silver nanoparticles than other metals are needed to induce significant inflammation.
This work was supported by NIOSH Grant R01OH009448 and NIEHS Grant P30 ES05605. We thank Drs. Jonas Baltrusaitis and Sherrie Elzey for help with XPS and TEM analyses.
- Peters TM, Elzey S, Johnson R, Park H, Grassian VH, Maher T, O'Shaughnessy P: Airborne Monitoring to Distinguish Engineered Nanomaterials from Incidental Particles for Environmental Health and Safety. Journal of Occupational and Environmental Hygiene 2009, 6: 73–81. 10.1080/15459620802590058PubMedView Article
- Adachi K, Buseck PR: Hosted and free-floating metal-bearingatmospheric nanoparticles in Mexico city. Environmental Science & Technology 2010. asap article
- Buseck PR, Adachi K: Nanoparticles in the Atmosphere. Elements 2008, 4: 389–394. 10.2113/gselements.4.6.389View Article
- Baun A, Hartmann NB, Grieger KD, Hansen SF: Setting the limits for engineered nanoparticles in European surface waters - are current approaches appropriate? Journal of Environmental Monitoring 2009, 11: 1774–1781. 10.1039/b909730aPubMedView Article
- Kaegi R, Ulrich A, Sinnet B, Vonbank R, Wichser A, Zuleeg S, Simmler H, Brunner S, Vonmont H, Burkhardt M, Boller M: Synthetic TiO2 nanoparticle emission from exterior facades into the aquatic environment. Environmental Pollution 2008, 156: 233–239. 10.1016/j.envpol.2008.08.004PubMedView Article
- Wijnhoven SWP, Peijnenburg WJGM, Herberts CA, Hagens WI, Oomen AG, Heugens EHW, Roszek B, Bisschops J, Gosens I, Van De Meent D, et al.: Nano-silver - a review of available data and knowledge gaps in human and environmental risk assessment. Nanotoxicology 2009, 3: 109–138. 10.1080/17435390902725914View Article
- Kim YS, Kim JS, Cho HS, Rha DS, Kim JM, Park JD, Choi BS, Lim R, Chang HK, Chung YH, et al.: Twenty-eight-day oral toxicity, genotoxicity, and gender-related tissue distribution of silver nanoparticles in Sprague-Dawley rats. Inhalation Toxicology 2008, 20: 575–583. 10.1080/08958370701874663PubMedView Article
- Kim JS, Kuk E, Yu KN, Kim JH, Park SJ, Lee HJ, Kim SH, Park YK, Park YH, Hwang CY, et al.: Antimicrobial effects of silver nanoparticles. Nanomedicine-Nanotechnology Biology and Medicine 2007, 3: 95–101. 10.1016/j.nano.2006.12.001View Article
- Chen X, Schluesener HJ: Nanosilver: A nanoproduct in medical application. Toxicology Letters 2008, 176: 1–12. 10.1016/j.toxlet.2007.10.004PubMedView Article
- Hussain SM, Hess KL, Gearhart JM, Geiss KT, Schlager JJ: In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicology in Vitro 2005, 19: 975–983. 10.1016/j.tiv.2005.06.034PubMedView Article
- Hussain SM, Javorina AK, Schrand AM, Duhart HM, Ali SF, Schlager JJ: The Interaction of Manganese Nanoparticles with PC-12 Cells Induces Dopamine Depletion. Toxicol Sci 2006, 92: 456–463. 10.1093/toxsci/kfl020PubMedView Article
- Kvitek L, Vanickova M, Panacek A, Soukupova J, Dittrich M, Valentova E, Prucek R, Bancirova M, Milde D, Zboril R: Initial Study on the Toxicity of Silver Nanoparticles (NPs) against Paramecium caudatum. Journal of Physical Chemistry C 2009, 113: 4296–4300. 10.1021/jp808645eView Article
- Liu RT, Sun F, Zhang LJ, Zong WS, Zhao XC, Wang L, Wu RL, Hao XP: Evaluation on the toxicity of nanoAg to bovine serum albumin. Science of the Total Environment 2009, 407: 4184–4188. 10.1016/j.scitotenv.2009.01.042PubMedView Article
- Navarro E, Piccapietra F, Wagner B, Marconi F, Kaegi R, Odzak N, Sigg L, Behra R: Toxicity of Silver Nanoparticles to Chlamydomonas reinhardtii. Environmental Science & Technology 2008, 42: 8959–8964.View Article
- Lanone S, Rogerieux F, Geys J, Dupont A, Maillot-Marechal E, Boczkowski J, Lacroix G, Hoet P: Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines. Particle and Fibre Toxicology 2009, 6: 14. 10.1186/1743-8977-6-14PubMed CentralPubMedView Article
- Bar-Ilan O, Albrecht RM, Fako VE, Furgeson DY: Toxicity Assessments of Multisized Gold and Silver Nanoparticles in Zebrafish Embryos. Small 2009, 5: 1897–1910. 10.1002/smll.200801716PubMedView Article
- Soto K, Garza KM, Murr LE: Cytotoxic effects of aggregated nanomaterials. Acta Biomaterialia 2007, 3: 351–358. 10.1016/j.actbio.2006.11.004PubMedView Article
- Soto KF, Carrasco A, Powell TG, Garza KM, Murr LE: Comparative in vitro cytotoxicity assessment of some manufactured nanoparticulate materials characterized by transmission electron microscopy. Journal of Nanoparticle Research 2005, 7: 145–169. 10.1007/s11051-005-3473-1View Article
- AshaRani PV, Mun GLK, Hande MP, Valiyaveettil S: Cytotoxicity and Genotoxicity of Silver Nanoparticles in Human Cells. Acs Nano 2009, 3: 279–290. 10.1021/nn800596wPubMedView Article
- Sayes CM, Reed KL, Warheit DB: Assessing toxicity of fine and nanoparticles: Comparing in vitro measurements to in vivo pulmonary toxicity profiles. Toxicol Sci 2007, 97: 163–180. 10.1093/toxsci/kfm018PubMedView Article
- Seagrave J, McDonald JD, Mauderly JL: In vitro versus in vivo exposure to combustion emissions. Experimental and Toxicologic Pathology 2005, 57: 233–238. 10.1016/j.etp.2005.05.011PubMedView Article
- Brandenberger C, Rothen-Rutishauser B, Muhlfeld C, Schmid O, Ferron GA, Maier KL, Gehr P, Lenz AG: Effects and uptake of gold nanoparticles deposited at the air-liquid interface of a human epithelial airway model. Toxicology and Applied Pharmacology 2010, 242: 56–65. 10.1016/j.taap.2009.09.014PubMedView Article
- Grigg J, Tellabati A, Rhead S, Almeida GM, Higgins JA, Bowman KJ, Jones GD, Howes PB: DNA damage of macrophages at an air-tissue interface induced by metal nanoparticles. Nanotoxicology 2009, 3: 348–354. 10.3109/17435390903276917View Article
- Lenz AG, Karg E, Lentner B, Dittrich V, Brandenberger C, Rothen-Rutishauser B, Schulz H, Ferron GA, Schmid O: A dose-controlled system for air-liquid interface cell exposure and application to zinc oxide nanoparticles. Particle and Fibre Toxicology 2009, 6: 32. 10.1186/1743-8977-6-32PubMed CentralPubMedView Article
- Thorne PS, Adamcakova-Dodd A, Kelly KM, O'Neill ME, Duchaine C: Metalworking fluid with mycobacteria and endotoxin induces hypersensitivity pneumonitis in mice. American Journal of Respiratory and Critical Care Medicine 2006, 173: 759–768. 10.1164/rccm.200405-627OCPubMed CentralPubMedView Article
- Driscoll KE, Costa DL, Hatch G, Henderson R, Oberdorster G, Salem H, Schlesinger RB: Intratracheal instillation as an exposure technique for the evaluation of respiratory tract toxicity: Uses and limitations. Toxicol Sci 2000, 55: 24–35. 10.1093/toxsci/55.1.24PubMedView Article
- Osier M, Oberdorster G: Intratracheal inhalation vs intratracheal instillation: Differences in particle effects. Fundamental and Applied Toxicology 1997, 40: 220–227. 10.1006/faat.1997.2390PubMedView Article
- Quadros ME, Marr LC: Environmental and Human Health Risks of Aerosolized Silver Nanoparticles. Journal of the Air & Waste Management Association 2010, 60: 770–781.View Article
- Ji JH, Jung JH, Kim SS, Yoon JU, Park JD, Choi BS, Chung YH, Kwon IH, Jeong J, Han BS, et al.: Twenty-eight-day inhalation toxicity study of silver nanoparticles in Sprague-Dawley rats. Inhalation Toxicology 2007, 19: 857–871. 10.1080/08958370701432108PubMedView Article
- Takenaka S, Karg E, Moller W, Roth C, Ziesenis A: A morphologic study on the fate of ultrafine silver particles: Distribution pattern of phagocytized metallic silver in vitro and in vivo. Inhalation Toxicology 2000, 12: 291–299. 10.1080/08958370050165166View Article
- Takenaka S, Karg E, Roth C, Schulz H, Ziesenis A, Heinzmann U, Schramel P, Heyder J: Pulmonary and systemic distribution of inhaled ultrafine silver particles in rats. Environmental Health Perspectives 2001, 109: 547–551. 10.2307/3454667PubMed CentralPubMedView Article
- Sung JH, Ji JH, Yoon JU, Kim DS, Song MY, Jeong J, Han BS, Han JH, Chung YH, Kim J, et al.: Lung function changes in Sprague-Dawley rats after prolonged inhalation exposure to silver nanoparticles. Inhalation Toxicology 2008, 20: 567–574. 10.1080/08958370701874671PubMedView Article
- Elzey S, Grassian VH: Agglomeration, isolation and dissolution of commercially manufactured silver nanoparticles in aqueous environments. Journal of Nanoparticle Research 2010, 12: 14. 10.1007/s11051-009-9783-yView Article
- Pettibone JM, Adamcakova-Dodd A, Thorne PS, O'Shaughnessy PT, Weydert JA, Grassian VH: Inflammatory response of mice following inhalation exposure to iron and copper nanoparticles. Nanotoxicology 2008, 2: 189–204. 10.1080/17435390802398291View Article
- Stopford W, Turner J, Cappellini D, Brock T: Bioaccessibility testing of cobalt compounds. Journal of Environmental Monitoring 2003, 5: 675–680. 10.1039/b302257aPubMedView Article
- O'Shaughnessy PT, Achutan C, O'Neill ME, Thorne PS: A small whole-body exposure chamber for laboratory use. Inhalation Toxicology 2003, 15: 251–263.PubMedView Article
- Asgharian B, Price OT: Airflow distribution in the human lung and its influence on particle deposition. Inhalation Toxicology 2006, 18: 795–801. 10.1080/08958370600748687PubMedView Article
- Cassee FR, Freijer JI, Subramaniam R, Asgharian B, Miller FJ, van Bree L, Rombout PJA: Development of a model for human and rat airway particle deposition: implications for risk assessment. Bilthoven, the Netherlands: Dutch National Institute of Public Health and Environment (RIVM);; 1999.
- Mueller-Anneling LJ, O'Neill ME, Thorne PS: Biomonitoring for assessment of organic dust-induced lung inflammation. European Respiratory Journal 2006, 27: 1096–1101. 10.1183/09031936.06.00092204PubMedView Article
- Kvitek L, Panacek A, Soukupova J, Kolar M, Vecerova R, Prucek R, Holecova M, Zboril R: Effect of surfactants and polymers on stability and antibacterial activity of silver nanoparticles (NPs). Journal of Physical Chemistry C 2008, 112: 5825–5834. 10.1021/jp711616vView Article
- Grassian VH, O'Shaughnessy PT, Adamcakova-Dodd A, Pettibone JM, Thorne PS: Inhalation exposure study of titanium dioxide nanoparticles with a primary particle size of 2 to 5 nm. Environmental Health Perspectives 2007, 115: 397–402. 10.1289/ehp.9469PubMed CentralPubMedView Article
- Grassian VH, Adamcakova-Dodd A, Pettibone JM, O'Shaughnessy PT, Thorne PS: Inflammatory response of mice to manufactured titanium dioxide nanoparticles: Comparison of size effects through different exposure routes. Nanotoxicology 2007, 1: 211–226. 10.1080/17435390701694295View Article
- Kennedy AJ, Hull MS, Bednar AJ, Goss JD, Gunter JC, Bouldin JL, Vikesland PJ, Steevens JA: Fractionating Nanosilver: Importance for Determining Toxicity to Aquatic Test Organisms. Environ Sci Technol 2010, 44: 9571–9577. 10.1021/es1025382PubMedView Article
- Liu J, Hurt RH: Ion Release Kinetics and Particle Persistence in Aqueous Nano-Silver Colloids. Environ Sci Technol 2010, 44: 2169–2175. 10.1021/es9035557PubMedView Article
- Kreyling WG, Scheuchm G: Clearance of particles deposited in the lungs. In Particle-Lung Interactions. Edited by: Gehr P HJ. New York: Marcel Dekker; 2000:323–376.View Article
- Geiser M, Casaulta M, Kupferschmid B, Schulz H, Semirriler-Behinke M, Kreyling W: The role of macrophages in the clearance of inhaled ultrafine titanium dioxide particles. American Journal of Respiratory Cell and Molecular Biology 2008, 38: 371–376. 10.1165/rcmb.2007-0138OCPubMedView Article
- Trinchieri G, Pflanz S, Kastelein RA: The IL-12 family of heterodimeric cytokines: New players in the regulation of T cell responses. Immunity 2003, 19: 641–644. 10.1016/S1074-7613(03)00296-6PubMedView Article
- Sung JH, Ji JH, Park JD, Yoon JU, Kim DS, Jeon KS, Song MY, Jeong J, Han BS, Han JH, et al.: Subchronic Inhalation Toxicity of Silver Nanoparticles. Toxicol Sci 2009, 108: 452–461. 10.1093/toxsci/kfn246PubMedView Article
- Hyun JS, Lee BS, Ryu HY, Sung JH, Chung KH, Yu IJ: Effects of repeated silver nanoparticles exposure on the histological structure and mucins of nasal respiratory mucosa in rats. Toxicology Letters 2008, 182: 24–28. 10.1016/j.toxlet.2008.08.003PubMedView Article
- Adamcakova-Dodd A, Thorne PS, Grassian VH: In Vivo Toxicity Studies of Metal and Metal Oxide Nanoparticles. In Handbook of Systems Toxicology. Edited by: Daniel A Cascinao, Saura C Sahu. Chichester, UK: John Wiley & Sons, Ltd; 2011:803–834.
- Brunner TJ, Wick P, Manser P, Spohn P, Grass RN, Limbach LK, Bruinink A, Stark WJ: In vitro cytotoxicity of oxide nanoparticles: Comparison to asbestos, silica, and the effect of particle solubility. Environmental Science & Technology 2006, 40: 4374–4381.View Article
- Xia T, Kovochich M, Liong M, Madler L, Gilbert B, Shi HB, Yeh JI, Zink JI, Nel AE: Comparison of the Mechanism of Toxicity of Zinc Oxide and Cerium Oxide Nanoparticles Based on Dissolution and Oxidative Stress Properties. Acs Nano 2008, 2: 2121–2134. 10.1021/nn800511kPubMed CentralPubMedView Article
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.